Articles tagged with Statins
Researchers estimate that around 6.5 million older adults with low cholesterol and high C-reactive protein levels might benefit from statin therapy to prevent cardiovascular events. Expanding prescribing criteria to include CRP levels could potentially prevent thousands of heart attacks, strokes, and deaths each year.
Mayo Clinic researchers found that statin use reduced stroke severity and improved outcomes, even in patients with ideal cholesterol levels. The study suggests benefits beyond lipid lowering, including plaque stabilization and anti-inflammatory effects.
A new UCSF study using the Coronary Heart Disease Policy Model found that adherence to 2001 NCEP guidelines would be cost-effective in preventing and managing coronary heart disease, saving 20,000 heart attacks and 10,000 CHD deaths annually. Statin costs become negligible when prices fall below 50 cents per pill.
Researchers found that high-frequency telephone counseling with a dietician resulted in the same amount of weight loss as face-to-face counseling for obese patients taking sibutramine. Wider use of statins could be a cost-effective strategy to prevent heart disease, but may require reevaluation if pill costs are lower.
Continuing statin therapy is associated with a reduced risk of death over four to five years, even among those without diagnosed heart disease. Patients who took statins for at least 90% of the follow-up period showed a 45% lower risk of death compared to those who did not adhere to treatment.
Scientists tested atorvastatin and lovastatin in animal models but found no efficacy in preventing breast cancer. In contrast, tamoxifen and bexarotene showed significant reduction in mammary tumors when combined with statins.
A study published in Nature Medicine suggests that statin drugs can stabilize blood vessels and prevent leaks in people with cerebral cavernous malformation (CCM). The disease, which affects an estimated 1.5 million people in the US, has no known drug therapy and often requires brain surgery or radiation treatment.
A comprehensive review of nearly 900 studies on statin side effects reveals a spectrum of reported issues, from muscle problems to cognitive decline. The study also highlights the link between mitochondrial dysfunction and increased risk of adverse effects.
A recent analysis estimates that over 44.7 million older Americans may benefit from statin therapy, highlighting a significant gap in current treatment guidelines. The study found that nearly 80% of this segment of the population could potentially be recommended statin therapy if new criteria are adopted.
A recent study published in the American Journal of Roentgenology found that traditional risk assessment tools do not accurately predict coronary heart disease. The study analyzed 1,653 patients and found that 21% of those thought to need statin drugs did not require them, and 26% of those already taking statins had no detectable plaque.
New research from the University of Manchester has shown that even water-soluble statins can affect placental development, leading to worse pregnancy outcomes. Current guidelines recommend avoiding statins during pregnancy due to their potential risks, and this study supports these recommendations.
A Mayo Clinic study found that statins do not interfere with rituximab treatment for lymphomas. In fact, statins may slow the progression of certain types of lymphoma. The study included over 500 patients and showed that statin use did not affect treatment outcomes, but may even improve them in some cases.
Lack of data on statin safety and efficacy in children and youth raises concerns about potential risks. Experts recommend caution and alternative management tools, citing the need for further research.
A study by Dr. Nabil G. Seidah's team reveals that annexin A2 can inhibit PCSK9's degradation of the LDLR receptor, leading to lower bad cholesterol levels. This discovery paves the way for a new drug to target cardiovascular diseases.
A new study found that vitamin C supplements can lower concentrations of CRP, a central biomarker of inflammation linked to heart disease and diabetes. The study also found no benefit from daily doses of vitamin E.
A study by Michigan State University researcher Jill Slade examines the ties between statin medications and muscle weakness, fatigue, and deterioration. The research aims to better understand the side effects of statins and identify potential risks in susceptible individuals.
Researchers found that in-hospital statin use is associated with lower mortality in patients with severe sepsis. Additionally, repeated CPR in hospitalized patients has a high mortality rate, while remote teleintensivist care improves ICU and hospital length of stay and mortality rates. Furthermore, female hospital staff members have d...
Researchers present new approaches to identifying asthma triggers using in-home photography, while tadalafil shows promise as an adjunct therapy for PAH. In-hospital statin use may lower mortality rates in patients with severe sepsis. Flexible bronchoscopy also proves safe for retrieving aspirated metallic pins from Muslim scarves.
Popular cholesterol-busting drugs statins appear to lower men's PSA values along with their cholesterol levels. However, it remains unclear whether statins prevent prostate cancer growth or just mask it. The study found that PSA levels declined by an average of about four percent after starting statins.
A recent study found that statin use is associated with a decline in prostate-specific antigen (PSA) levels, suggesting potential benefits for prostate cancer screening and management. The study, which analyzed data from over 1,200 men, showed a median decline of 4.1% in PSA levels after starting statin therapy.
New research suggests that statins may significantly reduce the occurrence of venous thromboembolism in patients with solid organ tumors. The study found that patients receiving statins were less likely to develop blood clots, with a significant reduction in incidence compared to those who did not use statins.
A study found that individuals taking statins before hospitalization for pneumonia had a lower risk of death within 90 days, particularly among those older than 80 and with bacteremia. The benefits were seen primarily in the early phase of infection, suggesting that statin use is beneficial primarily in the initial stages of infection.
Researchers at Hospital for Special Surgery found that statins can prevent white blood cell activation and protect pregnancies in women with APS. The study suggests that statins may be used as a treatment for women with APS-induced pregnancy complications.
Researchers found that high-dose statins can decrease satellite cell proliferation, potentially affecting muscle healing and repair. The study's findings suggest a need for further research on the effects of statins on muscle progenitor cells in older adults.
A retrospective cohort analysis involving over 280,000 patients found that statin use was associated with a 28% increased risk of postoperative delirium in elderly patients. The study also revealed that longer surgeries and age over 70 years increased the risk of delirium.
Researchers found that two statins can block the molecular pathway causing pregnancy loss in mice with antiphospholipid syndrome. The study suggests statins could be a treatment option for women experiencing similar complications.
Researchers have developed a dual treatment combining nanoparticles with a statin to stop the growth of blood vessels feeding arterial plaques. The treatment reduces plaque activity and prolongs stability in high-risk patients, offering hope for human clinical trials.
Researchers at McGill University found that discontinuing statin medication after a heart attack increases mortality risk by 88%. Patients who continued taking statins had a 16% lower risk of dying within the year, highlighting the importance of adhering to prescribed treatment.
Researchers presented innovative studies on sexual function, finding that statins can improve erectile function in men with metabolic syndrome. Additionally, new studies suggest that androgen therapy may restore sexual function faster post-prostatectomy than PDE 5 inhibitors.
A new study led by the University of Michigan found that people at high risk for dementia who took cholesterol-lowering statins were half as likely to develop dementia. The five-year study involved older Mexican-Americans with metabolic conditions and showed a significant reduction in dementia risk.
A study published in Neurology found that statin users were about half as likely to develop dementia as non-users. Researchers analyzed data from 1,674 Mexican Americans over 60 years old and found a significant association between statin use and reduced risk of cognitive decline.
A study found that patients receiving kidney transplants who took statin drugs had better survival rates compared to those who did not. Statin therapy was associated with a 36% lower risk of death in renal transplant recipients.
A randomized trial of simvastatin on cognitive function in children with NF1 found no significant improvement, but a potential benefit in object assembly scores. The study suggests that statins may not be effective in ameliorating cognitive deficits associated with the genetic disorder.
Researchers found a significant reduction in LDL cholesterol and triglycerides in patients taking fish oil and red yeast rice supplements. The study suggests a comprehensive approach to lipid lowering could be effective for patients unwilling or unable to take statins.
Researchers discovered that statins increase the development of oligodendrocytes from glial progenitor cells, a crucial reservoir for brain cell customization. The findings suggest potential benefits and risks associated with statin use in brain health and dementia prevention.
A gene variation called alternative splicing may explain why some people don't respond well to cholesterol-lowering drugs. Researchers found that this variation accounted for 9% of the reduced power of statins in lowering low-density lipoprotein (LDL) levels.
A Europe-wide survey revealed significant differences between heart doctors' treatment approaches, with many failing to adhere to recommended guidelines. However, a second study found that pre-operative statin therapy significantly reduces the risk of death and complications after cardiac surgery.
A study of 1,214 men prescribed cholesterol-lowering drugs found that PSA levels decreased after starting statins and correlated with LDL cholesterol decline. The results suggest a potential role for cholesterol in prostate cancer development and progression.
A large randomized drug trial found statins significantly reduce systolic and diastolic blood pressure, contributing to a reduced risk of stroke and cardiovascular events. The study involved 973 participants taking either simvastatin or pravastatin or a placebo for six months.
Researchers found that statins can modestly reduce systolic and diastolic blood pressure in individuals with hypertension. The study showed a significant decrease in blood pressure at six months of treatment, but not at one month.
A study of 7,290 participants in eight European countries identified patterns of person-to-person contact relevant to controlling the spread of infectious diseases. Statins impair antitumor effects of rituximab and antibody-dependent cellular cytotoxicity against B cell lymphoma cells.
A study found a rare but significant link between statin use and tendon complications, including tendonitis and rupture. Regular examination may be necessary for patients on statins, particularly during strenuous physical activity.
Researchers found that treatment with myriocin can significantly inhibit the progress of established atherosclerosis in mice, coinciding with decreases in sphingomyelin, cholesterol, and triglycerides. In contrast, statins may increase PCSK9 levels, which limits their benefit.
A study of 929 Catholic clergy members found no link between statin use and reduced risk of Alzheimer's disease. No association was also found between statins and slowed cognitive decline among older adults.
A meta-analysis of 18,686 individuals with diabetes and 71,370 without diabetes found a significant reduction in all-cause mortality and major vascular events with statin therapy. The study suggests that most people with diabetes should now be considered for statin therapy.
A study by Beth Israel Deaconess Medical Center has identified the atrogin-1 gene as a key player in statin-related muscle toxicity. The researchers found that statins activate this gene, leading to muscle damage and atrophy, with potential implications for patients taking these cholesterol-lowering drugs.
Researchers identified atrogin-1 as a key factor in statin-induced muscle damage, which can be prevented by inhibiting its function. This breakthrough may lead to new treatments for high cholesterol patients experiencing unwanted side effects.
A new study published at the American Heart Association's Scientific Sessions found that cholesterol-lowering medication simvastatin can disrupt sleep patterns in some individuals. Researchers compared two types of statins and observed a significant adverse effect on sleep quality among those taking simvastatin.
A new study found an association between statin use and reduced cognitive decline in elderly African Americans, with the strongest effect seen in those who discontinued use. The research suggests that the relationship between statins and cognitive decline is more complex than previously thought.
A retrospective study found that patients taking statin drugs alongside high-dose radiation therapy had a 10% higher chance of being cured of prostate cancer at 10 years after diagnosis. The study also showed reduced rates of cancer spreading to distant parts of the body in men who took statins during radiation treatment.
A study published in the American Journal of Respiratory and Critical Care Medicine found that statins reduce the annual loss of lung function in elderly individuals, including those who smoke. The researchers suggest that statins' ability to reduce inflammation and smoking-induced injury in the lungs may be responsible for this effect.
Researchers investigating statin effects on heart cells hope to understand disease process better and develop new treatments. The study, led by Dr Sarah Calaghan at the University of Leeds, aims to determine how statins affect caveolae and impact heart behavior.
People who stopped taking cholesterol-lowering drugs after a stroke are at greater risk of death or dependency. The study found that those who continued taking statins had a significantly lower risk of dying or becoming dependent on others.
Researchers found that statin treatment may curb Alzheimer's brain changes, with a study comparing brain scans of people who took statins to those who did not. The study, published in Neurology, included 110 Group Health members aged 65-79 and provided the first direct evidence of statin's potential protective effect on the brain.
Researchers found no relationship between statin use and reduced testosterone levels in men, suggesting poor health is a greater factor. Statin use was associated with lower total testosterone levels, but this association vanished when considering age, body weight, and other factors.
A Dutch study found that starting statin therapy at age 8 safely delays early artery damage caused by FH. The study showed that earlier initiation of statin treatment results in smaller carotid intima-media thickness at a later age, with no serious clinical or laboratory adverse events reported.
A recent study published in Mayo Clinic Proceedings found that patients prescribed cholesterol-lowering medications do not necessarily adopt unhealthy diets. Despite taking statins, patients made good faith efforts to improve their health through lifestyle changes.
A new study published by the American College of Cardiology found an association between low cholesterol levels and increased cancer risk. The research suggests that patients with high doses of statins may be at a higher risk of developing certain types of cancer.
A study published in BMC Medicine found that simvastatin is associated with a lower incidence of dementia and Parkinson's disease. The researchers analyzed data from over 700,000 simvastatin users and more than 50,000 atorvastatin users to confirm the benefits of simvastatin on these conditions.
A survey of 750 doctors from 10 countries found that only 47% of their patients reached cholesterol goals, but 61% deemed this acceptable. Doctors preferred prescribing statins and lifestyle changes over other approaches. Key findings showed significant variation in treatment recommendations across countries.